Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection
- PMID: 16542006
- PMCID: PMC1403748
- DOI: 10.1186/1745-6150-1-4
Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection
Abstract
Background: The mutation spectra of the TP53 gene and other tumor suppressors contain multiple hotspots, i.e., sites of non-random, frequent mutation in tumors and/or the germline. The origin of the hotspots remains unclear, the general view being that they represent highly mutable nucleotide contexts which likely reflect effects of different endogenous and exogenous factors shaping the mutation process in specific tissues. The origin of hotspots is of major importance because it has been suggested that mutable contexts could be used to infer mechanisms of mutagenesis contributing to tumorigenesis.
Results: Here we apply three independent tests, accounting for non-uniform base compositions in synonymous and non-synonymous sites, to test whether the hotspots emerge via selection or due to mutational bias. All three tests consistently indicate that the hotspots in the TP53 gene evolve, primarily, via positive selection. The results were robust to the elimination of the highly mutable CpG dinucleotides. By contrast, only one, the least conservative test reveals the signature of positive selection in BRCA1, BRCA2, and p16. Elucidation of the origin of the hotspots in these genes requires more data on somatic mutations in tumors.
Conclusion: The results of this analysis seem to indicate that positive selection for gain-of-function in tumor suppressor genes is an important aspect of tumorigenesis, blurring the distinction between tumor suppressors and oncogenes.
Reviewers: This article was reviewed by Sandor Pongor, Christopher Lee and Mikhail Blagosklonny.
Figures

Similar articles
-
High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.Cancer Res. 2009 Apr 15;69(8):3625-33. doi: 10.1158/0008-5472.CAN-08-3426. Epub 2009 Mar 31. Cancer Res. 2009. PMID: 19336573
-
BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.Cancer Lett. 2007 Apr 18;248(2):308-20. doi: 10.1016/j.canlet.2006.08.012. Epub 2006 Sep 22. Cancer Lett. 2007. PMID: 16996204
-
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.Hum Mutat. 2007 Jun;28(6):622-9. doi: 10.1002/humu.20495. Hum Mutat. 2007. PMID: 17311302
-
Significance of CpG methylation for solar UV-induced mutagenesis and carcinogenesis in skin.Photochem Photobiol. 2007 Jan-Feb;83(1):196-204. doi: 10.1562/2006-02-28-IR-822. Photochem Photobiol. 2007. PMID: 16620158 Review.
-
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.Oncogene. 2007 Apr 2;26(15):2157-65. doi: 10.1038/sj.onc.1210302. Oncogene. 2007. PMID: 17401424 Review.
Cited by
-
Identification of hot and cold spots in genome of Mycobacterium tuberculosis using Shewhart Control Charts.Sci Rep. 2012;2:297. doi: 10.1038/srep00297. Epub 2012 Mar 2. Sci Rep. 2012. PMID: 22389766 Free PMC article.
-
Molecular population genetics of PCSK9: a signature of recent positive selection.Pharmacogenet Genomics. 2008 Mar;18(3):169-79. doi: 10.1097/FPC.0b013e3282f44d99. Pharmacogenet Genomics. 2008. PMID: 18300938 Free PMC article.
-
An Electrochemical DNA Biosensor for Carcinogenicity of Anticancer Compounds Based on Competition between Methylene Blue and Oligonucleotides.Sensors (Basel). 2019 Nov 22;19(23):5111. doi: 10.3390/s19235111. Sensors (Basel). 2019. PMID: 31766637 Free PMC article.
-
Adaptive Evolution Hotspots at the GC-Extremes of the Human Genome: Evidence for Two Functionally Distinct Pathways of Positive Selection.Adv Bioinformatics. 2010;2010:856825. doi: 10.1155/2010/856825. Epub 2010 May 3. Adv Bioinformatics. 2010. PMID: 20454629 Free PMC article.
-
Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.PLoS Comput Biol. 2017 Apr 20;13(4):e1005428. doi: 10.1371/journal.pcbi.1005428. eCollection 2017 Apr. PLoS Comput Biol. 2017. PMID: 28426665 Free PMC article.
References
-
- Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes Dev. 1990;4:1–8. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous